BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: D'Alessio A, Proietti G, Sica G, Scicchitano BM. Pathological and Molecular Features of Glioblastoma and Its Peritumoral Tissue. Cancers (Basel) 2019;11:E469. [PMID: 30987226 DOI: 10.3390/cancers11040469] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 16.7] [Reference Citation Analysis]
Number Citing Articles
1 Palumbo P, Lombardi F, Augello FR, Giusti I, Luzzi S, Dolo V, Cifone MG, Cinque B. NOS2 inhibitor 1400W Induces Autophagic Flux and Influences Extracellular Vesicle Profile in Human Glioblastoma U87MG Cell Line. Int J Mol Sci 2019;20:E3010. [PMID: 31226744 DOI: 10.3390/ijms20123010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
2 Chato L, Latifi S. Machine Learning and Radiomic Features to Predict Overall Survival Time for Glioblastoma Patients. J Pers Med 2021;11:1336. [PMID: 34945808 DOI: 10.3390/jpm11121336] [Reference Citation Analysis]
3 Vasey CE, Cavanagh RJ, Taresco V, Moloney C, Smith S, Rahman R, Alexander C. Polymer Pro-Drug Nanoparticles for Sustained Release of Cytotoxic Drugs Evaluated in Patient-Derived Glioblastoma Cell Lines and In Situ Gelling Formulations. Pharmaceutics 2021;13:208. [PMID: 33546301 DOI: 10.3390/pharmaceutics13020208] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Haddad AF, Young JS, Amara D, Berger MS, Raleigh DR, Aghi MK, Butowski NA. Mouse models of glioblastoma for the evaluation of novel therapeutic strategies. Neurooncol Adv 2021;3:vdab100. [PMID: 34466804 DOI: 10.1093/noajnl/vdab100] [Reference Citation Analysis]
5 Daisy Precilla S, Biswas I, Kuduvalli SS, Anitha TS. Crosstalk between PI3K/AKT/mTOR and WNT/β-Catenin signaling in GBM - Could combination therapy checkmate the collusion? Cell Signal 2022;:110350. [PMID: 35525406 DOI: 10.1016/j.cellsig.2022.110350] [Reference Citation Analysis]
6 Mazurek M, Kulesza B, Stoma F, Osuchowski J, Mańdziuk S, Rola R. Characteristics of Fluorescent Intraoperative Dyes Helpful in Gross Total Resection of High-Grade Gliomas-A Systematic Review. Diagnostics (Basel) 2020;10:E1100. [PMID: 33339439 DOI: 10.3390/diagnostics10121100] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Bai Y, Qi W, Liu L, Zhang J, Pang L, Gan T, Wang P, Wang C, Chen H. Identification of Seven-Gene Hypoxia Signature for Predicting Overall Survival of Hepatocellular Carcinoma. Front Genet 2021;12:637418. [PMID: 33912215 DOI: 10.3389/fgene.2021.637418] [Reference Citation Analysis]
8 Neamati F, Asemi Z. The effects of melatonin on signaling pathways and molecules involved in glioma. Fundam Clin Pharmacol 2020;34:192-9. [PMID: 31808968 DOI: 10.1111/fcp.12526] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
9 Bander ED, Rivera M, Cisse B. The Benedict Arnold of the Central Nervous System Tumor Microenvironment? The Role of Microglia/Macrophages in Glioma. World Neurosurg 2021;154:214-21. [PMID: 34583498 DOI: 10.1016/j.wneu.2021.06.121] [Reference Citation Analysis]
10 Richard SA, Cui Q. The Pivotal Immunoregulatory Functions of Microglia and Macrophages in Glioma Pathogenesis and Therapy. Journal of Oncology 2022;2022:1-19. [DOI: 10.1155/2022/8903482] [Reference Citation Analysis]
11 Zheng B, Chen T. MiR-489-3p inhibits cell proliferation, migration, and invasion, and induces apoptosis, by targeting the BDNF-mediated PI3K/AKT pathway in glioblastoma. Open Life Sci 2020;15:274-83. [PMID: 33817216 DOI: 10.1515/biol-2020-0024] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Rahimi Koshkaki H, Minasi S, Ugolini A, Trevisi G, Napoletano C, Zizzari IG, Gessi M, Giangaspero F, Mangiola A, Nuti M, Buttarelli FR, Rughetti A. Immunohistochemical Characterization of Immune Infiltrate in Tumor Microenvironment of Glioblastoma. J Pers Med 2020;10:E112. [PMID: 32899203 DOI: 10.3390/jpm10030112] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
13 Haddad AF, Young JS, Aghi MK. Using viral vectors to deliver local immunotherapy to glioblastoma. Neurosurg Focus 2021;50:E4. [PMID: 33524947 DOI: 10.3171/2020.11.FOCUS20859] [Reference Citation Analysis]
14 Gaya-Bover A, Hernández-López R, Alorda-Clara M, Ibarra de la Rosa JM, Falcó E, Fernández T, Company MM, Torrens-Mas M, Roca P, Oliver J, Sastre-Serra J, Pons DG. Antioxidant enzymes change in different non-metastatic stages in tumoral and peritumoral tissues of colorectal cancer. Int J Biochem Cell Biol 2020;120:105698. [PMID: 31981728 DOI: 10.1016/j.biocel.2020.105698] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
15 Stylli SS. Novel Treatment Strategies for Glioblastoma. Cancers (Basel) 2020;12:E2883. [PMID: 33049911 DOI: 10.3390/cancers12102883] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
16 Yang B, Pan YB, Ma YB, Chu SH. Integrated Transcriptome Analyses and Experimental Verifications of Mesenchymal-Associated TNFRSF1A as a Diagnostic and Prognostic Biomarker in Gliomas. Front Oncol 2020;10:250. [PMID: 32257943 DOI: 10.3389/fonc.2020.00250] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Khodadadi H, Salles ÉL, Alptekin A, Mehrabian D, Rutkowski M, Arbab AS, Yeudall WA, Yu JC, Morgan JC, Hess DC, Vaibhav K, Dhandapani KM, Baban B. Inhalant Cannabidiol Inhibits Glioblastoma Progression Through Regulation of Tumor Microenvironment. Cannabis Cannabinoid Res 2021. [PMID: 34918964 DOI: 10.1089/can.2021.0098] [Reference Citation Analysis]
18 Rado M, Fisher D. The Paracrine Effect of Hypoxic and Normoxic Cancer Secretion on the Proliferation of Brain Endothelial Cells (bEnd.3). Cells 2022;11:1197. [DOI: 10.3390/cells11071197] [Reference Citation Analysis]
19 Geng W, Zou H, Wang H, Dai Y, Lu G, Sun Z, Lu Y, Ding X, Yu Y. Dual-triggered biomimetic vehicles enable treatment of glioblastoma through a cancer stem cell therapeutic strategy. Nanoscale 2021;13:7202-19. [PMID: 33889875 DOI: 10.1039/d0nr08899d] [Reference Citation Analysis]
20 Altieri R, Barbagallo D, Certo F, Broggi G, Ragusa M, Di Pietro C, Caltabiano R, Magro G, Peschillo S, Purrello M, Barbagallo G. Peritumoral Microenvironment in High-Grade Gliomas: From FLAIRectomy to Microglia-Glioma Cross-Talk. Brain Sci 2021;11:200. [PMID: 33561993 DOI: 10.3390/brainsci11020200] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
21 Alimohammadi E, Bagheri SR, Sadeghsalehi A, Rizevandi P, Rezaie Z, Abdi A. Prognostic factors in patients with glioblastoma multiforme: focus on the pathologic variants. Acta Neurol Belg 2020;120:1341-50. [PMID: 31222512 DOI: 10.1007/s13760-019-01171-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
22 Bang-Christensen SR, Pedersen RS, Pereira MA, Clausen TM, Løppke C, Sand NT, Ahrens TD, Jørgensen AM, Lim YC, Goksøyr L, Choudhary S, Gustavsson T, Dagil R, Daugaard M, Sander AF, Torp MH, Søgaard M, Theander TG, Østrup O, Lassen U, Hamerlik P, Salanti A, Agerbæk MØ. Capture and Detection of Circulating Glioma Cells Using the Recombinant VAR2CSA Malaria Protein. Cells 2019;8:E998. [PMID: 31466397 DOI: 10.3390/cells8090998] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
23 Ghinda DC, Lambert B, Lu J, Jiang N, Tsai E, Sachs A, Wu JS, Northoff G. Scale-Free Analysis of Intraoperative ECoG During Awake Craniotomy for Glioma. Front Oncol 2020;10:625474. [PMID: 33708619 DOI: 10.3389/fonc.2020.625474] [Reference Citation Analysis]
24 Wang J, Matosevic S. NT5E/CD73 as Correlative Factor of Patient Survival and Natural Killer Cell Infiltration in Glioblastoma. J Clin Med 2019;8:E1526. [PMID: 31547570 DOI: 10.3390/jcm8101526] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
25 Klamminger GG, Gérardy JJ, Jelke F, Mirizzi G, Slimani R, Klein K, Husch A, Hertel F, Mittelbronn M, Kleine-Borgmann FB. Application of Raman spectroscopy for detection of histologically distinct areas in formalin-fixed paraffin-embedded glioblastoma. Neurooncol Adv 2021;3:vdab077. [PMID: 34355170 DOI: 10.1093/noajnl/vdab077] [Reference Citation Analysis]
26 Angelucci C, D'Alessio A, Sorrentino S, Biamonte F, Moscato U, Mangiola A, Sica G, Iacopino F. Immunohistochemical Analysis of DNA Repair- and Drug-Efflux-Associated Molecules in Tumor and Peritumor Areas of Glioblastoma. Int J Mol Sci 2021;22:1620. [PMID: 33562724 DOI: 10.3390/ijms22041620] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Ustun M, Rahmani Dabbagh S, Ilci IS, Bagci-Onder T, Tasoglu S. Glioma-on-a-Chip Models. Micromachines (Basel) 2021;12:490. [PMID: 33926127 DOI: 10.3390/mi12050490] [Reference Citation Analysis]
28 Biamonte F, Sica G, Filippini A, D'Alessio A. Evidence of Reelin Signaling in GBM and Its Derived Cancer Stem Cells. Brain Sci 2021;11:745. [PMID: 34205192 DOI: 10.3390/brainsci11060745] [Reference Citation Analysis]
29 Thellung S, Corsaro A, Bosio AG, Zambito M, Barbieri F, Mazzanti M, Florio T. Emerging Role of Cellular Prion Protein in the Maintenance and Expansion of Glioma Stem Cells. Cells 2019;8:E1458. [PMID: 31752162 DOI: 10.3390/cells8111458] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
30 Peng K, Mawamba V, Schulz E, Löhr M, Hagemann C, Schatzschneider U. iClick Reactions of Square-Planar Palladium(II) and Platinum(II) Azido Complexes with Electron-Poor Alkynes: Metal-Dependent Preference for N1 vs N2 Triazolate Coordination and Kinetic Studies with 1H and 19F NMR Spectroscopy. Inorg Chem 2019;58:11508-21. [PMID: 31393709 DOI: 10.1021/acs.inorgchem.9b01304] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
31 Zhao M, van Straten D, Broekman MLD, Préat V, Schiffelers RM. Nanocarrier-based drug combination therapy for glioblastoma. Theranostics 2020;10:1355-72. [PMID: 31938069 DOI: 10.7150/thno.38147] [Cited by in Crossref: 37] [Cited by in F6Publishing: 45] [Article Influence: 18.5] [Reference Citation Analysis]
32 Gan C, Pierscianek D, El Hindy N, Ahmadipour Y, Keyvani K, Sure U, Zhu Y. The predominant expression of cancer stem cell marker ALDH1A3 in tumor infiltrative area is associated with shorter overall survival of human glioblastoma. BMC Cancer 2020;20:672. [PMID: 32680476 DOI: 10.1186/s12885-020-07153-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
33 Fan X, Yang H, Zhao C, Hu L, Wang D, Wang R, Fang Z, Chen X. Local anesthetics impair the growth and self-renewal of glioblastoma stem cells by inhibiting ZDHHC15-mediated GP130 palmitoylation. Stem Cell Res Ther 2021;12:107. [PMID: 33541421 DOI: 10.1186/s13287-021-02175-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
34 Redekar SS, Varma SL, Bhattacharjee A. Identification of key genes associated with survival of glioblastoma multiforme using integrated analysis of TCGA datasets. Computer Methods and Programs in Biomedicine Update 2022;2:100051. [DOI: 10.1016/j.cmpbup.2022.100051] [Reference Citation Analysis]
35 Finch EA, Duke E, Hwang EI, Packer RJ. Immunotherapy Approaches for Pediatric CNS Tumors and Associated Neurotoxicity. Pediatr Neurol 2020;107:7-15. [PMID: 32113728 DOI: 10.1016/j.pediatrneurol.2020.01.004] [Reference Citation Analysis]
36 Rado M, Flepisi B, Fisher D. The Effect of Normoxic and Hypoxic U-87 Glioblastoma Paracrine Secretion on the Modulation of Brain Endothelial Cells. Cells 2022;11:276. [DOI: 10.3390/cells11020276] [Reference Citation Analysis]
37 Persano F, Gigli G, Leporatti S. Natural Compounds as Promising Adjuvant Agents in The Treatment of Gliomas. IJMS 2022;23:3360. [DOI: 10.3390/ijms23063360] [Reference Citation Analysis]
38 Tsitlakidis A, Tsingotjidou AS, Kritis A, Cheva A, Selviaridis P, Aifantis EC, Foroglou N. Atomic Force Microscope Nanoindentation Analysis of Diffuse Astrocytic Tumor Elasticity: Relation with Tumor Histopathology. Cancers (Basel) 2021;13:4539. [PMID: 34572766 DOI: 10.3390/cancers13184539] [Reference Citation Analysis]
39 Kong F, Li X, Li S, Sheng D, Li W, Song M. MicroRNA-15a-5p promotes the proliferation and invasion of T98G glioblastoma cells via targeting cell adhesion molecule 1. Oncol Lett 2021;21:103. [PMID: 33376536 DOI: 10.3892/ol.2020.12364] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Azambuja JH, Ludwig N, Yerneni S, Rao A, Braganhol E, Whiteside TL. Molecular profiles and immunomodulatory activities of glioblastoma-derived exosomes. Neurooncol Adv 2020;2:vdaa056. [PMID: 32642708 DOI: 10.1093/noajnl/vdaa056] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
41 Galli R, Meinhardt M, Koch E, Schackert G, Steiner G, Kirsch M, Uckermann O. Rapid Label-Free Analysis of Brain Tumor Biopsies by Near Infrared Raman and Fluorescence Spectroscopy-A Study of 209 Patients. Front Oncol 2019;9:1165. [PMID: 31750251 DOI: 10.3389/fonc.2019.01165] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
42 Jena LN, Bennie LA, McErlean EM, Pentlavalli S, Glass K, Burrows JF, Kett VL, Buckley NE, Coulter JA, Dunne NJ, McCarthy HO. Exploiting the anticancer effects of a nitrogen bisphosphonate nanomedicine for glioblastoma multiforme. J Nanobiotechnology 2021;19:127. [PMID: 33947409 DOI: 10.1186/s12951-021-00856-x] [Reference Citation Analysis]
43 De La Cruz Minyety J, Shuboni-Mulligan DD, Briceno N, Young D Jr, Gilbert MR, Celiku O, Armstrong TS. Association of Circadian Clock Gene Expression with Glioma Tumor Microenvironment and Patient Survival. Cancers (Basel) 2021;13:2756. [PMID: 34199348 DOI: 10.3390/cancers13112756] [Reference Citation Analysis]
44 Zhang S, Xu Y, Zhao P, Bao H, Wang X, Liu R, Xu R, Xiang J, Jiang H, Yan J, Wu X, Shao Y, Liang J, Wu Q, Zhang Z, Lu S, Ma S. Integrated Analysis of Genomic and Immunological Features in Lung Adenocarcinoma With Micropapillary Component. Front Oncol 2021;11:652193. [PMID: 34221970 DOI: 10.3389/fonc.2021.652193] [Reference Citation Analysis]
45 Fløgstad Svensson S, Fuster-Garcia E, Latysheva A, Fraser-Green J, Nordhøy W, Isam Darwish O, Thokle Hovden I, Holm S, Vik-Mo EO, Sinkus R, Eeg Emblem K. Decreased tissue stiffness in glioblastoma by MR elastography is associated with increased cerebral blood flow. Eur J Radiol 2021;147:110136. [PMID: 35007982 DOI: 10.1016/j.ejrad.2021.110136] [Reference Citation Analysis]
46 Yang Q, Zhang J, Zhang X, Miao L, Zhang W, Jiang Z, Zhou W. C-C motif chemokine ligand 2/C-C receptor 2 is associated with glioma recurrence and poor survival. Exp Ther Med 2021;21:564. [PMID: 33850536 DOI: 10.3892/etm.2021.9996] [Reference Citation Analysis]
47 Tong N, He Z, Ma Y, Wang Z, Huang Z, Cao H, Xu L, Zou Y, Wang W, Yi C, Yin Z, Wang Q. Tumor Associated Macrophages, as the Dominant Immune Cells, Are an Indispensable Target for Immunologically Cold Tumor-Glioma Therapy? Front Cell Dev Biol 2021;9:706286. [PMID: 34368156 DOI: 10.3389/fcell.2021.706286] [Reference Citation Analysis]
48 Ogawa K, Kurose A, Kamataki A, Asano K, Katayama K, Kurotaki H. Giant cell glioblastoma is a distinctive subtype of glioma characterized by vulnerability to DNA damage. Brain Tumor Pathol 2020;37:5-13. [PMID: 31655917 DOI: 10.1007/s10014-019-00355-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
49 D'Souza S, Hirt L, Ormond DR, Thompson JA. Retrospective analysis of hemispheric structural network change as a function of location and size of glioma. Brain Commun 2021;3:fcaa216. [PMID: 33501423 DOI: 10.1093/braincomms/fcaa216] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
50 Haddad AF, Young JS, Mummaneni NV, Kasahara N, Aghi MK. Immunologic aspects of viral therapy for glioblastoma and implications for interactions with immunotherapies. J Neurooncol 2021;152:1-13. [PMID: 33389564 DOI: 10.1007/s11060-020-03684-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
51 Mowday AM, Lieuwes NG, Biemans R, Marcus D, Rezaeifar B, Reniers B, Verhaegen F, Theys J, Dubois LJ. Use of a Luciferase-Expressing Orthotopic Rat Brain Tumor Model to Optimize a Targeted Irradiation Strategy for Efficacy Testing with Temozolomide. Cancers (Basel) 2020;12:E1585. [PMID: 32549357 DOI: 10.3390/cancers12061585] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Gharahkhani R, Pourhadi M, Mirdamadi NS, Dana N, Rafiee L, Nedaeinia R, Javanmard SH. Effect of Anti-Podoplanin on Malignant Glioma Cell Viability, Invasion and Tumor Cell-Induced Platelet Aggregation. Archives of Medical Research 2022. [DOI: 10.1016/j.arcmed.2022.05.003] [Reference Citation Analysis]
53 Wang LM, Banu MA, Canoll P, Bruce JN. Rationale and Clinical Implications of Fluorescein-Guided Supramarginal Resection in Newly Diagnosed High-Grade Glioma. Front Oncol 2021;11:666734. [PMID: 34123831 DOI: 10.3389/fonc.2021.666734] [Reference Citation Analysis]
54 Nunno VD, Franceschi E, Gatto L, Brandes AA. BET inhibitors: the promise of a new generation of immunotherapy in glioblastoma. Immunotherapy 2021. [PMID: 34850637 DOI: 10.2217/imt-2021-0296] [Reference Citation Analysis]
55 Ibarra LE, Vilchez ML, Caverzán MD, Milla Sanabria LN. Understanding the glioblastoma tumor biology to optimize photodynamic therapy: From molecular to cellular events. J Neurosci Res 2021;99:1024-47. [PMID: 33370846 DOI: 10.1002/jnr.24776] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
56 Colapietro A, Yang P, Rossetti A, Mancini A, Vitale F, Martellucci S, Conway TL, Chakraborty S, Marampon F, Mattei V, Gravina GL, Biordi AL, Wei D, Newman RA, Festuccia C. The Botanical Drug PBI-05204, a Supercritical CO2 Extract of Nerium Oleander, Inhibits Growth of Human Glioblastoma, Reduces Akt/mTOR Activities, and Modulates GSC Cell-Renewal Properties. Front Pharmacol 2020;11:552428. [PMID: 33013390 DOI: 10.3389/fphar.2020.552428] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
57 La Rocca G, Simboli GA, Vincenzoni F, Rossetti DV, Urbani A, Ius T, Della Pepa GM, Olivi A, Sabatino G, Desiderio C. Glioblastoma CUSA Fluid Protein Profiling: A Comparative Investigation of the Core and Peripheral Tumor Zones. Cancers (Basel) 2020;13:E30. [PMID: 33374813 DOI: 10.3390/cancers13010030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
58 Cai Z, Zhang J, Liu Z, Su J, Xu J, Li Z, Meng H, Zhang H, Huang M, Zhao D, Duan C, He X. Identification of an N6-methyladenosine (m6A)-related signature associated with clinical prognosis, immune response, and chemotherapy in primary glioblastomas. Ann Transl Med 2021;9:1241. [PMID: 34532378 DOI: 10.21037/atm-21-3139] [Reference Citation Analysis]
59 Tran VL, Novell A, Tournier N, Gerstenmayer M, Schweitzer-Chaput A, Mateos C, Jego B, Bouleau A, Nozach H, Winkeler A, Kuhnast B, Larrat B, Truillet C. Impact of blood-brain barrier permeabilization induced by ultrasound associated to microbubbles on the brain delivery and kinetics of cetuximab: An immunoPET study using 89Zr-cetuximab. J Control Release 2020;328:304-12. [PMID: 32860928 DOI: 10.1016/j.jconrel.2020.08.047] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
60 Xiao Y, Wang Z, Zhao M, Deng Y, Yang M, Su G, Yang K, Qian C, Hu X, Liu Y, Geng L, Xiao Y, Zou Y, Tang X, Liu H, Xiao H, Fan R. Single-Cell Transcriptomics Revealed Subtype-Specific Tumor Immune Microenvironments in Human Glioblastomas. Front Immunol 2022;13:914236. [DOI: 10.3389/fimmu.2022.914236] [Reference Citation Analysis]
61 Kumar M, Nanga RPR, Verma G, Wilson N, Brisset JC, Nath K, Chawla S. Emerging MR Imaging and Spectroscopic Methods to Study Brain Tumor Metabolism. Front Neurol 2022;13:789355. [DOI: 10.3389/fneur.2022.789355] [Reference Citation Analysis]
62 Luo Y, Yang H, Zhou YF, Hu B. Dual and multi-targeted nanoparticles for site-specific brain drug delivery. J Control Release 2020;317:195-215. [PMID: 31794799 DOI: 10.1016/j.jconrel.2019.11.037] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
63 Parmigiani E, Scalera M, Mori E, Tantillo E, Vannini E. Old Stars and New Players in the Brain Tumor Microenvironment. Front Cell Neurosci 2021;15:709917. [PMID: 34690699 DOI: 10.3389/fncel.2021.709917] [Reference Citation Analysis]